Skip to main content
. 2020 Jun 27;20(9):2305–2317. doi: 10.1111/ajt.16059

TABLE 1.

Technical comparison of gene expression analysis using formalin‐fixed paraffin‐embedded (FFPE) tissue with NanoString nCounter vs fresh tissue with DNA microarrays

Feature FFPE tissue with NanoString nCounter Fresh tissue with cDNA microarrays
Maximum number of transcript targets 800 >47 000 a
Off‐the‐shelf panels available Yes Yes
Custom panels available Yes Yes
Recommended RNA input quantity 100 ng 50‐500 ng
Requires reverse transcription/amplification No Yes
Approximate assay turnaround time b 24‐40 h 25.5‐37.5 h
Analysis software provided by manufacturer Yes c Yes d
Ability to use same sample for histology and gene expression analysis, that is, ability for histomolecular integration Yes No
Immediate access to long‐term clinical follow‐up data on archival clinical samples (FFPE) Yes No
Food and Drug Administration approved

Yes for platform

Yes for specific clinical assays e

No for platform

Yes for specific clinical assay f

Approximate assay cost per sample g $275 $1000‐3000
Integration with local (decentralized) clinical workflow Simple due to local testing (no shipment of samples) on regulatory approved platform using simple open source analytics Complex (shipment of sample to referral lab, no regulatory approval of platform, complex analytics)
a

Affymetrix GeneChip Human Genome U133 Plus 2.0 Array.

b

Dependent on multiple variables: instrument settings, RNA input quantity, technician experience, etc. Time excludes RNA extraction time and sample shipment time if applicable.

c

NanoString nSolver Analysis Software.

d

Affymetrix Transcriptome Analysis Console Software.

e

NanoString Prosigna Breast Cancer Prognostic Gene Signature Assay.

f

Roche AmpliChip CYP450 Test, a pharmacogenetics assay to determine the genotype of two cytochrome P450 enzymes: 2D6 and 2C19.

g

Including RNA isolation but excluding instrument expenses and labor for RNA extraction. Reagent cost varies with number of transcript targets and samples. Microarrays costs vary on scale of economy by provider.